Photoinduced Synthesis of Functionalized Oxacyclic Spirooxindoles Via Ring Expansion

Construction of Fused Oxacyclic Compounds via Dual α- and β-C-H Functionalization and Ring Decomposition of Cyclic Ethers

A new synthetic method for the synthesis of bicyclic scaffolds featuring a dihydropyran and tetrahydrofuran (THF) hybrid in the fashion of a fused structure with excellent syn-selectivity is realized via the reactions of enaminones and THF. In addition to displaying a dual role as both a cyclic fragment and a one-carbon synthon, the current method also shows a rarely known mode of two vicinal C-H bonds' functionalization in THF or analogous oxa-heterocycles.

Photoinduced synthesis of functionalized spiro[2.3]hexane via an additive-free approach

A general green protocol for the synthesis of spiro[2.3]hexane avoiding the use of harmful and toxic reagents is described. Spirocyclic scaffolds can be constructed by using alkenes of low reactivity under visible-light irradiation only. Several synthetic advantages of this method are exhibited, including mild conditions, good functional-group tolerance, operational simplicity, and scalability. Mechanistic studies indicate that C-C bond formation occurs almost simultaneously with a light-sustained initiation process.

Metal-Free Regioselective Oxa-Michael Approach to Access Spirooxindole-Fused Tetrahydrofuran/Tetrahydropyran through [3 + 2]/ [4 + 2] Spirocyclization of Methyleneindolinones with Haloalcohols

An efficient one-pot metal-free, base-catalyzed method has been developed for the regioselective [3 + 2]/[4 + 2] annulation reactions of electrophilic methyleneindolinones with haloalcohols to furnish spirooxindole derivatives under mild reaction conditions. This reaction afforded the corresponding products with two contiguous stereocenters including a quaternary center in good to excellent yield (up to 95%) with moderate to good diastereoselectivities (up to 12.5:1 dr) with complete regioselectivity.

X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model

The secretory glutaminyl cyclase (sQC) and Golgi-resident glutaminyl cyclase (gQC) are responsible for N-terminal protein pyroglutamation and associated with various human diseases. Although several sQC/gQC inhibitors have been reported, only one inhibitor, PQ912, is currently undergoing clinic trials for the treatment of Alzheimer's disease. We report an X-ray crystal structure of sQC complexed with PQ912, revealing that the benzimidazole makes "anchor" interactions with the active site zinc ion and catalytic triad. Structure-guided design and optimization led to a series of new benzimidazole derivatives exhibiting nanomolar inhibition for both sQC and gQC. In a MPTP-induced Parkinson's disease (PD) mouse model, BI-43 manifested efficacy in mitigating locomotor deficits through reversing dopaminergic neuronal loss, reducing microglia, and decreasing levels of the sQC/gQC substrates, α-synuclein, and CCL2. This study not only offers structural basis and new leads for drug discovery targeting sQC/gQC but also provides evidence supporting sQC/gQC as potential targets for PD treatment.

Highly enantio- and diastereoselective construction of spirocyclic oxindoles via a palladium-catalyzed decarboxylative asymmetric [4 + 2] annulation strategy

A palladium-catalyzed decarboxylative asymmetric [4 + 2] annulation of methyleneindolinones with a zwitterionic oxo-1,4-dipole intermediate was successfully developed to access spirocyclic oxindoles bearing two vicinal stereocenters in good yields with high diastereoselectivities and enantioselectivities. This strategy features a broad substrate scope (28 examples), allowing for efficient scale-up. Further selective transformation of the product and preliminary mechanistic studies were conducted.

Visible photons as ideal reagents for the activation of coloured organic compounds

In recent decades, the traceless nature of visible photons has been exploited for the development of efficient synthetic strategies for the photoconversion of colourless compounds, namely, photocatalysis, chromophore activation, and the formation of an electron donor/acceptor (EDA) complex. However, the use of photoreactive coloured organic compounds is the optimal strategy to boost visible photons as ideal reagents in synthetic protocols. In view of such premises, the present review aims to provide its readership with a collection of recent photochemical strategies facilitated via direct light absorption by coloured molecules. The protocols have been classified and presented according to the nature of the intermediate/excited state achieved during the transformation.

The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents

In this study, a new series of spiro indolin-1,2-diazepine were designed, synthesized, and screened for their cholinesterase inhibitory activities. A novel, green, high-yielding approach was constructed to synthesize spiro indolin-1,2-diazepine derivatives through a cascade reaction of different isatins, malononitrile and 1,1-enediamines (EDAMs) via sequential four-component reactions to produce the target compounds with good to excellent yields. Next the inhibitory potencies of all derivatives were determined spectroscopically at 415 nm using the modified Ellman method. The results of the in vitro screening indicated that 5l with spiroindolin-1,2-diazepine core bearing 5-NO₂ at R¹ and 4-OH at R² was the most potent and selective AChE inhibitor with an IC₅₀ value of 3.98 ± 1.07 µM with no significant inhibition against BChE while 5j was the most active analog against both AChE and BChE enzymes. The structure-activity relationships suggested the variation in the inhibitory activities of derivatives was affected by different substitutions on the indolinone ring as well as the phenyl moiety. The enzyme kinetic studies of the most potent compound 5l at five different concentrations and acetylthiocholine substrate (0.1-1 mM) by Ellman's method revealed that it inhibited AChE in a mixed mode with a K_i of 0.044 μM. A molecular docking study was performed via induced fit docking protocol to predict the putative binding interaction. It was shown that the moieties used in the initial structure design play a fundamental role in interacting with the enzyme's binding site. Further, molecular dynamics simulations with the Schrödinger package were performed for 5l in a complex with AChE and revealed that compound 5l formed the stable complex with the enzyme. The MTT toxicity assessments against the neuroblastoma cell line were executed, and no toxicity was seen for 5l under the tested concentrations.